(Hypertension. 1999;34:525-530.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Third Department of Internal Medicine, Osaka Medical College, Takatsuki City, Osaka, Japan.
Correspondence to Hikaru Nishimura, MD, Third Department of Internal Medicine, Osaka Medical College, 2-7 Daigakumachi, Takatsuki City, Osaka 569-8686, Japan. E-mail in3023{at}poh.osaka-med.ac.jp
AbstractContrary to previous reports, recent enzymatic assays showed the predominance of chymase-like activity in rat arteries. We determined the existence and significance of such alternative pathways in rat carotid arteries by measuring contraction of arterial rings in organ baths and blood pressure in conscious rats. Hamster aorta served as a positive control for chymase. Temocapril (30 µmol/L) inhibited the contractions to angiotensin (Ang) I (10-9 to 10-5 mol/L) except at high concentrations of Ang I (>10-7 mol/L). Addition of chymostatin (100 µmol/L) to temocapril exerted a synergistic inhibitory effect. Hamster aorta gave similar results, except that temocapril was 30-fold less effective than in rat arteries. [Pro11,D-Ala12]Ang I (10-8 to 10-5 mol/L), a chymase-specific substrate, provoked similar responses in rat and hamster arteries; chymostatin, but not temocapril, attenuated the responses. CV 11974 (30 µmol/L), an Ang II type 1 receptor antagonist, abolished the responses to both peptides. In conscious rats, Ang I (0.03 to 30 µg/kg) and [Pro11,D-Ala12]Ang I (7 to 700 µg/kg) produced similar pressor responses. Not only CV 11974 (1 mg/kg) but also temocapril (2 mg/kg) abolished Ang Iinduced responses in vivo. CV 11974, but not temocapril, inhibited responses to [Pro11,D-Ala12]Ang I. Our results showed the presence of the alternative pathway in rat arteries, but it did not play a major role. Arteries with the opposing characteristics of chymase responded equally to [Pro11,D-Ala12]Ang I. These findings suggest that biochemical and [Pro11,D-Ala12]Ang Iderived results may not reflect the functional significance of chymase.
Key Words: angiotensin-converting enzyme chymase aorta carotid arteries hamster
This article has been cited by other articles:
![]() |
P. L. Diaz-Sylvester, M. C. Fiori, S. M. Dieguez, A. C. Muller, M. L. Lopardo, and C. E. Amorena Effect of chronic inhibition of converting enzyme on proximal tubule acidification Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R2014 - R2020. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Sartorio, D. Fraccarollo, P. Galuppo, M. Leutke, G. Ertl, I. Stefanon, and J. Bauersachs Mineralocorticoid Receptor Blockade Improves Vasomotor Dysfunction and Vascular Oxidative Stress Early After Myocardial Infarction Hypertension, November 1, 2007; 50(5): 919 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Santos, M. A. V. Caprio, E. B. Oliveira, M. C. O. Salgado, D. N. Schippers, D. H. Munzenmaier, and A. S. Greene Functional role, cellular source, and tissue distribution of rat elastase-2, an angiotensin II-forming enzyme Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H775 - H783. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tom, I. M. Garrelds, E. Scalbert, A. P.A. Stegmann, F. Boomsma, P. R. Saxena, and A.H. J. Danser ACE- Versus Chymase-Dependent Angiotensin II Generation in Human Coronary Arteries: A Matter of Efficiency? Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 251 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. McDonald, N. Padmanabhan, M. C. Petrie, C. Hillier, J. M.C. Connell, and J. J.V. McMurray Vasoconstrictor Effect of the Angiotensin-Converting Enzyme-Resistant, Chymase-Specific Substrate [Pro11D-Ala12] Angiotensin I in Human Dorsal Hand Veins: In Vivo Demonstration of Non-ACE Production of Angiotensin II in Humans Circulation, October 9, 2001; 104(15): 1805 - 1808. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Inoue, H. Nishimura, J. Kubota, and Y. Kitaura Nitric oxide mediates inhibitory effect of losartan on angiotensin-induced contractions in hamster but not rat aorta Journal of Renin-Angiotensin-Aldosterone System, June 1, 2000; 1(2): 180 - 183. [Abstract] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |